Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
QuintilesIMS
Mallinckrodt
Cipla
Medtronic
Novartis
Citi
Daiichi Sankyo
Argus Health

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,336,400

« Back to Dashboard

Summary for Patent: 4,336,400
Title: 3-(Hydroxy or hydroxymethyl)-4-hydroxy-alpha(aminomethyl)benzyl alcohols and methods of use
Abstract:Mono-, di- and tri-esters of 3-(hydroxy or hydroxymethyl)-4-hydroxy-alpha-(aminomethyl)benzyl alcohols, obtained by methods involving reduction of the corresponding mono- and di-ester ketones, are useful for producing sympathomimetic effects, such as bronchodilation, of long duration with low cardiovascular stimulating effect, in warm-blooded mammals.
Inventor(s): Minatoya; Hiroaki (East Greenbush, NY), Tullar; Benjamin F. (Laurel Park, NC), Conway; Walter D. (Amherst, NY)
Assignee: Sterling Drug Inc. (New York, NY)
Application Number:05/937,949
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 4,336,400

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,336,400

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 300762 ➤ Subscribe
Belgium 748178 ➤ Subscribe
Canada 923132 ➤ Subscribe
Switzerland 522589 ➤ Subscribe
Germany 2015573 ➤ Subscribe
Denmark 131459 ➤ Subscribe
Spain 378092 ➤ Subscribe
Finland 54796 ➤ Subscribe
Finland 773437 ➤ Subscribe
Finland 61686 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Queensland Health
Citi
QuintilesIMS
Fuji
Daiichi Sankyo
Argus Health
Cipla
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot